Yokohama, Japan

Hiroyuki Kuzuhara


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Kanagawa-ken, JP (2001)
  • Yokohama, JP (2001 - 2006)

Company Filing History:


Years Active: 2001-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hiroyuki Kuzuhara: Innovator in Triterpene Derivatives

Introduction

Hiroyuki Kuzuhara is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of triterpene derivatives for the treatment of liver diseases. With a total of 4 patents to his name, Kuzuhara continues to push the boundaries of innovation in healthcare.

Latest Patents

One of his latest patents focuses on triterpene derivatives and remedies for liver diseases. This patent discloses a triterpene derivative that is useful for treating hepatic disorders. The compound comprises an active ingredient represented by a specific formula, where various groups can be substituted to enhance its therapeutic efficacy. This innovative approach aims to provide new treatment options for individuals suffering from liver-related ailments.

Career Highlights

Kuzuhara is currently associated with Meiji Seika Kaisha, Ltd., a company known for its commitment to research and development in the pharmaceutical sector. His work has been instrumental in advancing the understanding of triterpene compounds and their potential applications in medicine.

Collaborations

Throughout his career, Kuzuhara has collaborated with esteemed colleagues such as Kazue Sasaki and Nobuto Minowa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Hiroyuki Kuzuhara stands out as a prominent figure in the field of medicinal chemistry, particularly for his innovative work on triterpene derivatives. His contributions not only advance scientific knowledge but also hold promise for improving patient outcomes in liver disease treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…